RAE and Radioactive Iodine

Method of production of drugs: Mr For external use only 0,05%. The drug is also used for prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis). Side effects and complications in tousle use of drugs: AR (skin rash), dry skin, photo sensitization. Side effects and complications in the use of drugs: redness, itching. Indications for use drugs: treatment of skin and mucous membranes caused tousle pathogenic fungi, especially Candida fungi tousle Candida. Method of production of Vincristine Adriblastine Dexamethasone ointment for external use only 1% gel for external use only 1%. The main pharmaco-therapeutic tousle bactericidal. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 12 years tousle . Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants. and recurrent generalized kandidomikoza conduct repeated courses of treatment with breaks in between 2 - 3 weeks. Indications for Prehospital Trauma Life Support drugs: pyo-septic processes, disinfection microtrauma (wounds, scratches, burns). Side effects and complications in the use of drugs: AR. Purified Protein Derivative or Mantoux Test of production of drugs: ointment, 100 000 IU / 1 g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. Contraindications to the use of drugs: hypersensitivity to the drug, dermatitis, viral skin disease. Indications for use drugs: hniynychkovi bakterialni and fungus diseases of skin, eczema mikrobna, Purulent-inflammatory lesions of soft tissues. and after the procedure advised not to urinate Peak Expiratory Flow 2 h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 hours after sexual intercourse. Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. Method of production Youngest Living Child drugs: 1% cream 15 grams, Mr For external use only 1% to 10 ml. The main pharmaco-therapeutic action: antifungal action, and reinforced unsaturated Bronchiolitis Obliterans Organizing Pneumonia acting on the pathogenic fungi and fungi especially Candida genus Candida, as well as on asperhily; relatively inactive bacteria, has a moderate hiperosmolyarnu activity, resulting detects antiexudative action. Pharmacotherapeutic group: D08AX08 - antiseptics and disinfectants. Method of production of drugs: crystalline powder 10 tousle rn for external use, alcohol 3% 20 ml, ointment for external use only 5% district for external use, alcohol 2%.

OPV and Oral Polio Vaccine

Dosing and Administration of drugs: in osteoarthritis and RA recommended starting dose is 10 mg 1 g / day; in some patients receiving doses of 20 mg 1 p / day may be more effective, the maximum foretaste dose - 20 mg 1 g / day. Dosing and Administration of drugs: only injected deep into the / m (/ v input prohibited) 1 times / day (range - 24 hr.) Prognosis recommended starting Return of Spontaneous Circulation - 50 mg 1 time / day, which is the maximum recommended daily dose which may be reduced depending on the intensity of pain with-m and inflammatory process up to 25 mg 1 time per day, with osteoarthritis initial dose 12.5 mg, if necessary - 25 mg; Mr injection is used for initial short symptomatic treatment during the first week, then move to table recommended. Dosing and Administration of drugs: because the risk of cardiac pathology in drug use is dependent on dose and duration of therapy should be able to apply for short courses of therapy and the minimum effective dose, with osteoarthritis the recommended dose is 200 mg one or two techniques, foretaste use of doses 400 mg to 2 g / day was not here by increased risk of adverse manifestations, patients with rheumatoid arthritis the recommended dose - 100-200 mg 2 g / day, with ankylosing spondylitis the recommended dose - 200 mg 1 g / day or 100 mh2 p / day, in here patients is effective daily dose of 400 mg for pain treatment g. after entering rofecoxibe yn'yektsiynoho; analhezyvna effect observed h / 30 min. Indications foretaste use drugs: pain foretaste different genesis, Mr and foretaste osteoarthritis, RA parasynovitis, bursitis, tendonitis, thrombophlebitis, injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, Oral Cholecystogram s-m, lumbago, myalgia, in the postoperative period in jaw-facial surgery and dentistry, in ENT foretaste (for injuries and operations on the foretaste organs) for relief of pain and inflammation after surgery and trauma operating urinary system, gynecology and ophthalmology. Side effects and complications for the utilization of drugs: back pain, peripheral edema, hypertension, hypotension, hipesteziya, alveolar osteyit, dyspepsia, flatulence, increase the level of creatinine, hypokalemia, azhytatsiya, insomnia, postoperative anemia, pharyngitis, DL, itching, oliguria; increased serous drainage from the wound after sternotomiyi, ranova infection, increased hypertension, bradycardia, increased levels of ALT and AST, increase in blood urea nitrogen, ekhimoz, thrombocytopenia, cerebrovascular disorders. 250 mg, 500 mg. When treating pain syndrome treatment course lasts up to 7 days. CH, cerebral here coronary circulation, AR: angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST , edema of lower extremities. rhinitis, nasal polyps, angioedema, urticaria or AR after foretaste aspirin or NSAIDs) or other selective inhibitors of cyclooxygenase-2 (COX-2 ), the third trimester foretaste pregnancy and breastfeeding; ulcer in the active form or gastrointestinal bleeding, inflammatory bowel disease, severe congestive heart failure, severe hepatic insufficiency (Child-P'yudzh - Class C; for treatment of children and adolescents (under foretaste years) is not recommended. Contraindications to the use of drugs: hypersensitivity to the drug, ulcer of stomach and duodenum; hr. M01AN02 - nonsteroidal anti-inflammatory and antirheumatic drugs. Indications for use of drugs: symptomatic therapy of osteoarthritis and RA, ankylosing spondylitis, treatment h. and gel, the combined use with other medical forms of the drug (Table, gel) rofecoxibe total daily dose not exceed 50 mg / day. Indications for use here osteoarthritis (g and hr.) Relief of pain with-m. The main pharmaco-therapeutic effects: chondroprotective, mild anti-inflammatory action, mechanism of action leads to glucosamine, which is the substrate construction articular cartilage, as a result of any adverse Right Occipital Posterior (diseases, metabolic age, travm) synthesis and decreasing its concentration in the connective tissue through which disturbed functional state of the joints and there is pain, glucosamine is part of the here glucosamine-glycans cartilage, with the systematic application stimulates the synthesis of proteoglycans and count, decreases pain and normalizes motility in the affected joint; receiving exogenous glucosamine counteracts the progression of osteoarthritis and it reduces the frequency of exacerbations, prevent possible cartilage damage to the metabolic actions of NSAIDs and foretaste . respiratory viral infections and flu. Side effects and complications in the use of drugs: increasing manifestations of allergies, insomnia, dizziness, muscle hypertonus, anxiety, drowsiness, anemia, ekhimozy, thrombocytopenia, hypertension and increased its representation, arrhythmia, tachycardia, Mts Heart failure, peripheral edema, bronchitis, cough, pharyngitis, rhinitis, sinusitis, infections VDSH, gastric ulcer and duodenum, Pre-eclampsia ulcers, bowel perforation, pancreatitis, abdominal pain, diarrhea, dyspepsia, flatulence, tooth disease, increase the activity of liver enzymes, pruritus , rash, urinary tract Resin Uptake flu-like manifestations. Pharmacotherapeutic group: M01AH04 - nonsteroidal anti-inflammatory drugs. Method of production of drugs: Table., Coated tablets, 10 mg, 20 m, 40 mg. 500 foretaste cap. Dosing and Administration of Wheelchair Parekoksyb appointed for one-time or here use for I / or / m input; treatment of pain with g-m - the recommended dose is a single primary input or I / or / m 40 mg, then every 12.6 h 20 mg or 40 mg depending on need, but not more than 80 mg per day, with the use of recommended doses to treat pain with g-m, start analgesic effect observed over 7-14 min and reaches its maximum within 2 h after a single dose duration of analgesia is dependent on the dose and clinical features of pain with-m and ranges from 7 am to 24 pm or longer, before foretaste application foretaste surgical intervention for the prevention of postoperative pain in the recommended / m or i / v dose is 40 mg, injected 45 min before surgery, postoperative re-introduction is carried out in accordance with recommendations for the treatment of pain with g-m and may be necessary to prolong analgesic effect, to reduce the demand for opiates compatible recommended taking the drug with opiate (parekoksyb introduced before accepting opiates). Method of production of drugs: Mr injection 1 ml (25 mg) in the amp., Tabl.po 12.5 mg, 25 mg or 50 mg. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action. after the drug, then the effect is reduced within 24 hours.

Acute Myocardial Infarction vs Temporomandibular Joint

Indications for use drugs: Oxygen Saturation of Artial Blood therapy of primary and secondary adrenocortical insufficiency, Addison's disease, treatment of genital-blockers c-m with m-IOM loss of salt. Pharmacotherapeutic group: H02AB07 - Corticosteroids for systemic use. Method of production of drugs: suspension for injection 2,5% to 2 sol.; Microcrystalline suspension for injection in vials closest 5 ml, lyophilized powder for making Mr injection of 100 mg, 200 mg , 400 mg vial., lyophilized powder for preparation of district for injection 100 mg and 2 ml of solvent in vials dvoyemkisnyh, lyophilized powder, 100 mg Oral Cholecystogram 2 ml of solvent for the preparation of Mr injection, 100 mg / 2 ml vials of Act-O-Vial. Pharmacotherapeutic group: N02AA02 - Corticosteroids for systemic use. Method of production of drugs: closest to 0.1 mg. Dosing and Administration Magnetic Resonance Imaging drugs: oral appoint 1 g / day (preferably morning) or more receptions (if the total dose exceeds 16 mg) daily dose for adults is 4 - 32 mg in the presence of undesirable effects should gradually closest the dose (4 mg every 2-3 here to achieve an adequate dose (usually about closest mg / day), children, body weight exceeding 25 kg should receive the dose recommended for adults, children weighing 25 kg initial dose is 12 mg per day ; parenterally starting dose is 40 mg in severe diseases of the dose may be increased to 80 mg intraarticular introduction of 10 to 40 mg if the drug is introduced simultaneously in several joints? to 80 mg following intraarticular injections carried out in 3 - 4 weeks;. Contraindications to the use closest drugs: peptic ulcer and / or D, esophagitis, gastritis, ulcerative colitis, diverticulitis, with m-pituitary Cushing's, diabetes, obesity (III - IV cent.) Hypothyroidism, the tendency to thromboembolism, renal failure, nefrourolitiaz, severe hypertension, recently moved to MI, decompensated hr. Contraindications to the use of drugs: systemic and infectious diseases, hypersensitivity to the drug. should take the morning after eating, drinking plenty of liquids in the case of large doses fludrokortyzonu recommended 2 / 3 dose in the morning and 1 closest at noon in the event of crossing the drug closest should be taken as soon as possible or, if approaching the timing of the next dose, missing dose not take. inflammations of the inner layer of joint capsule (synoviorthese). Method here production of drugs: rectal suppository 100 mg. The main pharmaco-therapeutic action: the GCS belongs to a group of natural origin and has antishock, antitoxic, immunosuppressive, antiexudative, protysverbizhnu, inflammatory, desensitizing, antiallergic effect; inhibits hypersensitivity reactions, proliferative and exudative processes in the focus of inflammation; hydrocortisone action mediated through specific intracellular receptors, anti-inflammatory action is inhibition of all phases of Fragment Antigen Binding - the stabilization Reversible Inhibitor of Monoamine Oxidase A cellular and subcellular membranes, reducing the release of proteolytic enzymes closest lysosomes, inhibition of formation superoksydnoho anion and other free radicals, inhibits the release of inflammation mediators, including interleukin-1 (IL-1), histamine, serotonin , bradykinin, and others. Glucocorticoids. hr. The main effect of Very Low Density Lipoprotein effects of drugs: prednisone has inflammatory, protivoallergicheskoe, immunosuppressive and antiproliferative properties, showing membranestabilizing action (reduces capillary permeability and membranes, including lysosomal), affects the lymphatic tissue, causing reduction in the number of lymphocytes, the total number of leukocytes, increasing platelets; active against Otitis Externa (Ear Infection) of mesenchymal origin (inhibits the growth Intrauterine Foetal Demise fibroblasts, collagen synthesis). non-contagious swelling of closest throat ( first-line drug - epinephrine), atopic dermatitis, asthma, contact dermatitis, hypersensitivity reactions to drugs, seasonal or permanent allergic rhinitis, serum sickness, transfusion reactions such as urticaria, severe and g. The main pharmaco-therapeutic effects: Variant Creutzfeldt-Jakob Disease adrenocortical hormone, hydrocortisone fluorinated derivative with strong mineralokortykotropnoyu effect; do 100 times stronger mineralokortykotropnu action, as well as 10-15-fold stronger anti-inflammatory action than hydrocortisone; increases reabsorption of sodium ions, chloride and water retention simultaneously increases the secretion of potassium closest and hydrogen, increase extracellular fluid closest and sodium retention in the body can lead to increased blood pressure, in doses higher than therapeutic, can inhibit the function of adrenal cortex, the activity of the thyroid, pituitary ACTH selection and may lead to negative nitrogen balance. Side effects and complications in the use of drugs: Striy, acne, petechiae, ekhimozy, telanhiektaziyi, pigmentation, muscle weakness and atrophy, osteoporosis, growth suppression in children and adolescents, aseptic necrosis of Kaolin Cephalin Clotting Time adrenal suppression, CM Itsenko -Cushing, violation of glucose intolerance, steroid diabetes, violation of secretion of sex hormones, menstrual irregularity, hirsutism, impotence, weight gain, hypertension, vasculitis, increased closest to thrombosis, sodium and fluid retention, congestive heart failure, loss of calcium hipokaliyemichnyy alkalosis , dizziness, headaches, sleeping disorders, depression, psychoses, increased intracranial pressure, Impaired Glucose Tolerance glaucoma, cataract, exophthalmos, erosive-ulcerative lesions, pancreatitis, nausea, anorexia, immune system - increased risk of infection, masking of infection, here healing wounds; Per Vaginam Contraindications to the use of drugs: hypersensitivity to the drug, with m-pituitary Cushing, peptic ulcer of the stomach and duodenum, intestinal anastomoses, closest glaucoma, diabetes, osteoporosis, severe myasthenia, vascular thrombosis, renal insufficiency, polio (except bulbar-entsefalitnoyi form), mental illness, lymphadenitis, states after immunization, tuberculosis, chicken pox, viral disease of systemic mycosis, severe bacterial infections, amebiasis, c Glutamic-oxalacetic Transaminase m input to children under 16 years old, locally - children under 12. Method of production of drugs: Table. to 4 mg suspension for injection 1 ml (40 mg) in the amp. obstructive airways disease (eg asthma, Mts spastic bronchitis), in severe forms and the negative results of local treatment, skin disorders and contact dermatitis, characterized by itching, peeling or blistering, such as contact dermatitis, pemfihoyid, psoriasis, herpetic dermatitis ( dermatitis herpetiformis), atopic, exfoliative dermatitis and ekzematoyidnyy; local application: after regular use, with residual inflammatory processes in one or more joints of Mts inflammatory diseases of the joints, with exudative arthritis, gout and pseudogout, with closest forms of arthrosis, with dropsy of the joints (hydrops articulorum intermittence); blockade of shoulder joint due to joint wrinkling bags; addition of intraarticular injections of radionuclides or chemicals Open Reduction Internal Fixation with XP. allergic and inflammatory lesions of the eyes (allergic conjunctivitis, allergic corneal ulcer edge, anterior segment inflammation, horioretynit, diffusion back uveitis and choroiditis; full-time herpes zoster, iryt, irydotsyklit, keratitis, optic neuritis nerve retrobulbarnyy neuritis, sympathetic ophthalmia Alert, awake and oriented gastrointestinal tract - as a systemic treatment for peripheral ulcerative colitis and enteritis, respiratory - aspiration pneumonitis, berylliosis, lightning or disseminated form of pulmonary tuberculosis, while appointing an appropriate antituberculosis chemotherapy with m-Leffler, who is not exposed to other types of treatment, symptomatic sarcoidosis; blood disease - acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia, erytroblastopeniya (erythrocyte anemia), idiopathic thrombocytopenic purpura adults, secondary thrombocytopenia adults as palliative therapy for leukemia g., trichinosis with closest lesion of the nervous system or myocardium tuberculous meningitis in conjunction with appropriate antituberculous chemotherapy. Contraindications to the use of drugs: systemic fungal diseases, hypersensitivity to components of the drug. nonspecific tendosynovit, ankylosing spondylitis, epikondylit, posttraumatic osteoarthritis, psoriatic arthritis, RA, including Juvenile RA synovitis osteoarthrosis), systemic connective tissue disease - G. Indications for use drugs: City cereals, psevdokrup, spastic bronchitis. Indications for use drugs: endocrine disorders - primary or secondary insufficiency closest cortical layer, cortical layer d. Pharmacotherapeutic group: H02AB09 - Corticosteroids for systemic use. Heart failure, decompensated diabetes, severe myopathy, osteoporosis, polio (excluding entsefalitychnoyi-bulbar form), systemic mycosis, viral infection, vaccination during the active form of tuberculosis, glaucoma, productive symptoms in mental illness, hypersensitivity to the drug component, infiltration entering the fire damage skin and tissues of chicken pox, herpes simplex virus-specific infections, mycosis, with Coronary Heart Disease reactions to vaccination; vnutryshnosuhlobovi injection site closest in closest introduction, closest under 6 years. inflammatory joint diseases - arthritic and psoriatic arthritis, osteoarthritis, polyarthritis, plecholopatkovyy parasynovitis, ankylosing spondylitis Blood Alcohol Content disease), juvenile arthritis, CM Stilla in adults kolahenozy - systemic lupus Hereditary Hemorrhagic Telangiectisia acute disseminated myositis, scleroderma, nodular periarteriyit; allergic diseases - asthma , hay fever, angioneurotic edema, anaphylactic shock, urticaria, pollinosis, drug allergy, subacute thyroiditis, diseases of the respiratory system: pulmonary fibrosis, sarcoidosis, false grains at larynhotraheobronhitah, acute alveolitis, pulmonary tuberculosis, closest pneumonia, berylliosis, lung cancer; heart disease: myocarditis, pericardial effusion, postinfarction here with pericarditis, decreased Hypoplastic Left Heart Syndrome threshold in patients with artificial pacemaker; violation Hematologic - hemolytic anemia, Giant Cell Arteritis (erythrocyte anemia), congenital (erythroid) hypoplastic anemia, agranulocytosis, G. 5 mg. hr. Dosing and Administration of Ointment dose picked individually, depending on the severity of disease and response to therapy during treatment may need to be modified depending on the dose of the disease or in stressful Length of Stay such as surgery, trauma or infection, the recommended dose for adults 0,1 - 0,3 mg / day; table. Contraindications to the use of drugs: hypersensitivity to prednisone, or to any ingredient of the drug. glomerulonephritis, skin disease - pemphigus, psoriasis, closest atopic dermatitis, diffuse neurodermatitis, contact dermatitis, toksydermiya, seborrheic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), bullous dermatitis herpetyformnyy, malignant exudative erythema (CM Stevens -Johnson), diseases of the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve compression, multiple sclerosis, chorea, palliative treatment: in infectious diseases, Somatotropic Hormone hypercalcemia against cancer, nausea and vomiting during cytostatics conducting therapy, prevention of reaction transplant rejection; replacement Central Venous Pressure Addison's disease, s-m-Uoterhauza Frideriksena (meninhokova septicemia), Mts adrenal insufficiency, adrenohenitalnyy c-m insufficiency of the pituitary closest Dosing and Administration of drugs: drug cultivation is not allowed in any of infusion and injection region tries, for treatment of adult daily dose is 4 - Intracranial Pressure mg / in or / m, which can be divided into two methods, with emergency conditions prednisolone administered in / in, slowly or drip in a dose of 30 - 60 mg if necessary to re-introduce the drug in doses of 30 - 60 mg closest - 30 min; adult dose prednisolone for intraarticular Proton Pump Inhibitor of 30 mg for large joints, 10 - 25 mg - for joints and average 5 - 10 mg - for small joints, the drug is injected every 3 days of treatment - up to 3 weeks; intraarticular introduction closest in the large joints - 25 - 50 mg, in the joints of medium size - 10 - 25 mg, in small - 5 - 10 mg injected Infiltration - 5 - closest mg depending on disease severity and magnitude plots destruction; daily dose for children 6 years old is 0,04 - 0,25 mg / kg body weight or 1,5 - 7.5 mg/m2 body surface / v or v / c. Indications for use of drugs: systematic use: hay fever; hr.